Cargando…
The synergy of β amyloid 1-42 and oxidative stress in the development of Alzheimer’s disease-like neurodegeneration of hippocampal cells
Alzheimer’s disease (AD) is a type of dementia that affects memory, thinking and behavior. Symptoms eventually become severe enough to interfere with daily tasks. Understanding the etiology and pathogenesis of AD is necessary for the development of strategies for AD prevention and/or treatment, and...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596457/ https://www.ncbi.nlm.nih.gov/pubmed/36284177 http://dx.doi.org/10.1038/s41598-022-22761-5 |
_version_ | 1784815874912288768 |
---|---|
author | Karapetyan, Gohar Fereshetyan, Katarine Harutyunyan, Hayk Yenkoyan, Konstantin |
author_facet | Karapetyan, Gohar Fereshetyan, Katarine Harutyunyan, Hayk Yenkoyan, Konstantin |
author_sort | Karapetyan, Gohar |
collection | PubMed |
description | Alzheimer’s disease (AD) is a type of dementia that affects memory, thinking and behavior. Symptoms eventually become severe enough to interfere with daily tasks. Understanding the etiology and pathogenesis of AD is necessary for the development of strategies for AD prevention and/or treatment, and modeling of this pathology is an important step in achieving this goal. β-amyloid peptide (Aβ) injection is a widely used approach for modeling AD. Nevertheless, it has been reported that the model constructed by injection of Aβ in combination with a prooxidant cocktail (ferrous sulfate, Aβ, and buthionine sulfoximine (BSO) (FAB)) best reflects the natural development of this disease. The relationship between oxidative stress and Aβ deposition and their respective roles in Aβ-induced pathology in different animal models of AD have been thoroughly investigated. In the current paper, we compared the effects of Aβ 1-42 alone with that of Aβ-associated oxidative stress induced by the FAB cocktail on the neurodegeneration of hippocampal cells in vitro. We constructed a FAB-induced AD model using rat primary hippocampal cells and analyzed the contribution of each compound. The study mainly focused on the prooxidant aspects of AD pathogenesis. Moreover, cellular bioenergetics was assessed and routine metabolic tests were performed to determine the usefulness of this model. The data clearly show that aggregated Aβ1-42 alone is significantly less toxic to hippocampal cells. Aggregated Aβ damages neurons, and glial cells proliferate to remove Aβ from the hippocampus. External prooxidant agents (Fe(2+)) or inhibition of internal antioxidant defense by BSO has more toxic effects on hippocampal cells than aggregated Aβ alone. Moreover, hippocampal cells fight against Aβ-induced damage more effectively than against oxidative damage. However, the combination of Aβ with external oxidative damage and inhibition of internal antioxidant defense is even more toxic, impairs cellular defense systems, and may mimic the late phase of AD-associated cell damage. Our findings strongly indicate a critical role for the combination of Aβ and oxidative stress in the development of neurodegeneration in vitro. |
format | Online Article Text |
id | pubmed-9596457 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-95964572022-10-27 The synergy of β amyloid 1-42 and oxidative stress in the development of Alzheimer’s disease-like neurodegeneration of hippocampal cells Karapetyan, Gohar Fereshetyan, Katarine Harutyunyan, Hayk Yenkoyan, Konstantin Sci Rep Article Alzheimer’s disease (AD) is a type of dementia that affects memory, thinking and behavior. Symptoms eventually become severe enough to interfere with daily tasks. Understanding the etiology and pathogenesis of AD is necessary for the development of strategies for AD prevention and/or treatment, and modeling of this pathology is an important step in achieving this goal. β-amyloid peptide (Aβ) injection is a widely used approach for modeling AD. Nevertheless, it has been reported that the model constructed by injection of Aβ in combination with a prooxidant cocktail (ferrous sulfate, Aβ, and buthionine sulfoximine (BSO) (FAB)) best reflects the natural development of this disease. The relationship between oxidative stress and Aβ deposition and their respective roles in Aβ-induced pathology in different animal models of AD have been thoroughly investigated. In the current paper, we compared the effects of Aβ 1-42 alone with that of Aβ-associated oxidative stress induced by the FAB cocktail on the neurodegeneration of hippocampal cells in vitro. We constructed a FAB-induced AD model using rat primary hippocampal cells and analyzed the contribution of each compound. The study mainly focused on the prooxidant aspects of AD pathogenesis. Moreover, cellular bioenergetics was assessed and routine metabolic tests were performed to determine the usefulness of this model. The data clearly show that aggregated Aβ1-42 alone is significantly less toxic to hippocampal cells. Aggregated Aβ damages neurons, and glial cells proliferate to remove Aβ from the hippocampus. External prooxidant agents (Fe(2+)) or inhibition of internal antioxidant defense by BSO has more toxic effects on hippocampal cells than aggregated Aβ alone. Moreover, hippocampal cells fight against Aβ-induced damage more effectively than against oxidative damage. However, the combination of Aβ with external oxidative damage and inhibition of internal antioxidant defense is even more toxic, impairs cellular defense systems, and may mimic the late phase of AD-associated cell damage. Our findings strongly indicate a critical role for the combination of Aβ and oxidative stress in the development of neurodegeneration in vitro. Nature Publishing Group UK 2022-10-25 /pmc/articles/PMC9596457/ /pubmed/36284177 http://dx.doi.org/10.1038/s41598-022-22761-5 Text en © The Author(s) 2022, corrected publication 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Karapetyan, Gohar Fereshetyan, Katarine Harutyunyan, Hayk Yenkoyan, Konstantin The synergy of β amyloid 1-42 and oxidative stress in the development of Alzheimer’s disease-like neurodegeneration of hippocampal cells |
title | The synergy of β amyloid 1-42 and oxidative stress in the development of Alzheimer’s disease-like neurodegeneration of hippocampal cells |
title_full | The synergy of β amyloid 1-42 and oxidative stress in the development of Alzheimer’s disease-like neurodegeneration of hippocampal cells |
title_fullStr | The synergy of β amyloid 1-42 and oxidative stress in the development of Alzheimer’s disease-like neurodegeneration of hippocampal cells |
title_full_unstemmed | The synergy of β amyloid 1-42 and oxidative stress in the development of Alzheimer’s disease-like neurodegeneration of hippocampal cells |
title_short | The synergy of β amyloid 1-42 and oxidative stress in the development of Alzheimer’s disease-like neurodegeneration of hippocampal cells |
title_sort | synergy of β amyloid 1-42 and oxidative stress in the development of alzheimer’s disease-like neurodegeneration of hippocampal cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596457/ https://www.ncbi.nlm.nih.gov/pubmed/36284177 http://dx.doi.org/10.1038/s41598-022-22761-5 |
work_keys_str_mv | AT karapetyangohar thesynergyofbamyloid142andoxidativestressinthedevelopmentofalzheimersdiseaselikeneurodegenerationofhippocampalcells AT fereshetyankatarine thesynergyofbamyloid142andoxidativestressinthedevelopmentofalzheimersdiseaselikeneurodegenerationofhippocampalcells AT harutyunyanhayk thesynergyofbamyloid142andoxidativestressinthedevelopmentofalzheimersdiseaselikeneurodegenerationofhippocampalcells AT yenkoyankonstantin thesynergyofbamyloid142andoxidativestressinthedevelopmentofalzheimersdiseaselikeneurodegenerationofhippocampalcells AT karapetyangohar synergyofbamyloid142andoxidativestressinthedevelopmentofalzheimersdiseaselikeneurodegenerationofhippocampalcells AT fereshetyankatarine synergyofbamyloid142andoxidativestressinthedevelopmentofalzheimersdiseaselikeneurodegenerationofhippocampalcells AT harutyunyanhayk synergyofbamyloid142andoxidativestressinthedevelopmentofalzheimersdiseaselikeneurodegenerationofhippocampalcells AT yenkoyankonstantin synergyofbamyloid142andoxidativestressinthedevelopmentofalzheimersdiseaselikeneurodegenerationofhippocampalcells |